Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Didierlaurent, AM"'
Autor:
Munoz, FM, Cramer, JP, Dekker, CL, Dudley, MZ, Graham, BS, Gurwith, M, Law, B, Perlman, S, Polack, F, Anderson, SV, Spergel, JM, Van Braeckel, Eva, Ward, B, Didierlaurent, AM, Lambert, PH
Publikováno v:
VACCINE
Vaccine
Vaccine
This is a Brighton Collaboration Case Definition of the term & ldquo;Vaccine Associated Enhanced Disease & rdquo; to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts conve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6cb264d2f8f94207fda1e2f26fe8bf
https://doi.org/10.1016/j.vaccine.2021.01.055
https://doi.org/10.1016/j.vaccine.2021.01.055
Autor:
Stylianou VV; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Bertram KM; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Vo VA; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Dunn EB; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Baharlou H; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Terre DJ; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Elhindi J; Research and Education Network, Western Sydney Local Health District, Westmead, New South Wales, Australia., Elder E; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; The Westmead Breast Cancer Institute, Westmead, New South Wales, Australia., French J; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; The Westmead Breast Cancer Institute, Westmead, New South Wales, Australia., Meybodi F; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; The Westmead Breast Cancer Institute, Westmead, New South Wales, Australia., Temmerman ST; GSK, Rixensart, Belgium., Didierlaurent AM; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Coccia M; GSK, Rixensart, Belgium., Sandgren KJ; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Cunningham AL; Centre for Virus Research, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.; Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Sep 24; Vol. 134 (22). Date of Electronic Publication: 2024 Sep 24.
Autor:
Klinkardt U; Speransa Therapeutics, TowerOne (Spaces), Frankfurt am Main, Germany., Schunk M; Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, Munich, Germany., Ervin J; AMR - Center for Pharmaceutical Research, Kansas City, MO, USA., Schindler C; Medizinische Hochschule Hannover (MHH), Center for Clinical Trials (ZKS) - Early Clinical Trial Unit (ECTU), Hanover, Germany., Sugimoto D; Cedar Crosse Research Cente, Chicago, IL, USA., Rankin B; Accel Research Sites (ARS) - Corporate Office, DeLand, FL, USA., Amann R; Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Monti M; VisMederi Srl, Siena, Italy., Kutschenko A; Medizinische Hochschule Hannover (MHH), Center for Clinical Trials (ZKS) - Early Clinical Trial Unit (ECTU), Hanover, Germany., Schumacher C; Medizinische Hochschule Hannover (MHH), Center for Clinical Trials (ZKS) - Early Clinical Trial Unit (ECTU), Hanover, Germany., Huber K; Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, Munich, Germany., Zeder A; Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, Munich, Germany., Heikkila N; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Didierlaurent AM; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Schwarz SE; Speransa Therapeutics, TowerOne (Spaces), Frankfurt am Main, Germany., Derouazi M; Speransa Therapeutics, TowerOne (Spaces), Frankfurt am Main, Germany.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2410574. Date of Electronic Publication: 2024 Oct 14.
Autor:
Bechtold V; GSK, Rixensart, 1330, Belgium., Smolen KK; GSK, Rixensart, 1330, Belgium.; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Faculty of Medicine, Université libre de Bruxelles (ULB), Brussels, 1070, Belgium., Burny W; GSK, Rixensart, 1330, Belgium., de Angelis SP; GSK, Rixensart, 1330, Belgium., Delandre S; GSK, Rixensart, 1330, Belgium., Essaghir A; GSK, Rixensart, 1330, Belgium., Marchant A; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Faculty of Medicine, Université libre de Bruxelles (ULB), Brussels, 1070, Belgium., Ndour C; Business and Decision Life Sciences c/o GSK, Rixensart, 1330, Belgium., Taton M; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Faculty of Medicine, Université libre de Bruxelles (ULB), Brussels, 1070, Belgium., van der Most R; GSK, Rixensart, 1330, Belgium., Willems F; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Faculty of Medicine, Université libre de Bruxelles (ULB), Brussels, 1070, Belgium., Didierlaurent AM; GSK, Rixensart, 1330, Belgium.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Jul 31; Vol. 16 (758), pp. eadl3381. Date of Electronic Publication: 2024 Jul 31.
Autor:
Gualtieri R; Pediatric Platform for Clinical Research, Department of Pediatrics, Gynecology and Obstetrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Yerly S; Laboratory of Virology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland., Garcia-Tarodo S; Unit of Pediatric Neurology, Division of Pediatric Specialties, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland., Parvex P; Unit of Pediatric Nephrology, Division of Pediatric Specialties, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland., Rock N; Pediatric Gastroenterology, Hepatology and Nutrition Unit, Department of Pediatrics, Gynecology and Obstetrics, Swiss Pediatric Liver Center, Geneva University Hospitals, Geneva, Switzerland.; Department of Pediatrics, Gynecology, and Obstetrics, Swiss Pediatric Liver Center, University of Geneva, University Hospitals of Geneva, Geneva, Switzerland., Posfay-Barbe K; Pediatric Platform for Clinical Research, Department of Pediatrics, Gynecology and Obstetrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Unit of Infectious Diseases, Division of General Pediatrics, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland., Didierlaurent AM; Department of Pathology and Immunology, Center for Vaccinology, University of Geneva, Geneva, Switzerland., Eberhardt C; Department of Pathology and Immunology, Center for Vaccinology, University of Geneva, Geneva, Switzerland.; Center for Vaccinology, University Hospitals of Geneva, Geneva, Switzerland., Blanchard-Rohner G; Unit of Immunology, Vaccinology and Rheumatology, Division of General Pediatrics, Department of Pediatrics, Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland.
Publikováno v:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2024 May; Vol. 35 (5), pp. e14161.
Autor:
Bekliz M; Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland., Thiriard A; European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium., Stringhini S; Population Epidemiology Unit, Primary Care Division, University of Geneva, Geneva, Switzerland., Marchant A; European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium., Didierlaurent AM; Centre of Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Meyer B; Centre of Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Blanchard-Rohner G; Centre of Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland, Unit of Pediatric Immunology, Rheumatology and Vaccinology, Children's Hospital of Geneva, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 May 01; Vol. 43 (5), pp. e189-e191. Date of Electronic Publication: 2024 Feb 02.
Autor:
Hentzien M; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; University of Reims Champagne-Ardenne, Reims, France., Bonnet F; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France., Bernasconi E; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland., Biver E; Division of Bone Diseases, Geneva University Hospitals, Geneva, Switzerland., Braun DL; Division Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Munting A; Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudoise (CHUV), Lausanne, Switzerland., Leuzinger K; Clinical Virology, University Hospital Basel, Basel, Switzerland., Leleux O; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France., Musardo S; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Prendki V; Division of Infectious Disease, Geneva University Hospital, Geneva, Switzerland., Schmid P; Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital, St Gallen, Switzerland., Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Walti CS; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Wittkop L; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, F-33000, France.; Inria équipe SISTM team, Talence, France., Appay V; Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, 33000, France., Didierlaurent AM; Department of Pathology and Immunology, Center of Vaccinology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. arnaud.didierlaurent@unige.ch., Calmy A; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. Alexandra.Calmy@hug.ch.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 19; Vol. 24 (1), pp. 329. Date of Electronic Publication: 2024 Mar 19.
Autor:
Martinez-Murillo PA; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Huttner A; Center for Vaccinology, Geneva University Hospitals, Geneva, Switzerland.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Center for Clinical Research, Geneva University Hospitals, Geneva, Switzerland., Lemeille S; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Medaglini D; Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy., Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Harandi AM; Department of Microbiology and Immunology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Vaccine Evaluation Centre, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada., Didierlaurent AM; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Siegrist CA; Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Center for Vaccinology, Geneva University Hospitals, Geneva, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jan 03; Vol. 14, pp. 1279003. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2023).
Autor:
Schuind AE; PATH, Washington DC, United States., Rees H; Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa., Schiller J; National Cancer Institute, National Institutes of Health, Bethesda, United States., Mugo N; Kenya Medical Research Institute, Nairobi, Kenya and Department of Global Health, University of Washington, Seattle, United States., Dull P; Vaccine Development, Bill & Melinda Gates Foundation, Seattle, United States., Barnabas R; Division of Infectious Diseases, Mass General Hospital, Harvard Medical School, Boston, United States., Clifford GM; Early Detection, Prevention, and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Liu G; Department of Global Health, University of Washington, Seattle, United States., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Johannesburg, South Africa., Morse RB; Centre of Vaccinology, University of Geneva, Switzerland., Moscicki AB; Department of Pediatrics, University of California Los Angeles, Los Angeles, United States., Palefsky JM; University of California, San Francisco School of Medicine, San Francisco, United States., Plotkin S; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States., Sierra MS; National Cancer Institute, National Institutes of Health, Bethesda, United States., Slifka MK; Oregon Health & Science University, Beaverton, United States., Vorsters A; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium., Kreimer AR; National Cancer Institute, National Institutes of Health, Bethesda, United States., Didierlaurent AM; Centre of Vaccinology, University of Geneva, Switzerland.
Publikováno v:
Preventive medicine reports [Prev Med Rep] 2023 Jul 19; Vol. 35, pp. 102331. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Autor:
Salmon DA; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Black S; Global Vaccine Data Network, Berkeley California, USA., Didierlaurent AM; Center of Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Moulton LH; Department of International Health, Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 May 29; Vol. 227 (11), pp. 1224-1226.